Birken AG clinical trials
Acquired by Chiesi Farmaceutici S.p.A., Apr 12, 2023 · source ↗
The registry lists 6 studies whose lead sponsor is Birken AG. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 19, 2018.
Before and after it joined Chiesi Farmaceutici S.p.A.
- First submitted before Birken AG became part of Chiesi Farmaceutici S.p.A.
- 6
- First submitted after Birken AG became part of Chiesi Farmaceutici S.p.A.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Birken AG6 studies
Something wrong with this grouping? Tell us on the Chiesi Farmaceutici S.p.A. page.
Studies
Recruiting first, then most recently updated. Showing 6 of 6. All Chiesi Farmaceutici S.p.A. studies →
- Oleogel-S10 in Wound Healing of Split-Thickness Skin Graft Donor Sites (BSG-12)CompletedNCT01807650Phase 3
Sponsor listed in the registry: Birken AG · First submitted before Birken AG became part of Chiesi Farmaceutici S.p.A.
- Oleogel-S10 in Wound Healing of Inherited Epidermolysis Bullosa (BEB-10)CompletedNCT01294241Phase 2
Sponsor listed in the registry: Birken AG · First submitted before Birken AG became part of Chiesi Farmaceutici S.p.A.
- Oleogel-S10 in Wound Healing of Split-Thickness Skin Graft Donor Sites (BSH-12)CompletedNCT01657305Phase 3
Sponsor listed in the registry: Birken AG · First submitted before Birken AG became part of Chiesi Farmaceutici S.p.A.
- Oleogel-S10 Versus Standard of Care in Healing of Grade 2a Burn WoundsCompletedNCT01657292Phase 3
Sponsor listed in the registry: Birken AG · First submitted before Birken AG became part of Chiesi Farmaceutici S.p.A.
- The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic KeratosesCompletedNCT00786994Phase 2
Sponsor listed in the registry: Birken AG · First submitted before Birken AG became part of Chiesi Farmaceutici S.p.A.
- Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Moist Wound Healing Dressing Alone in Accelerating the Epithelialization of Split Thickness Skin Graft Donor SitesCompletedNCT01294254Phase 2
Sponsor listed in the registry: Birken AG · First submitted before Birken AG became part of Chiesi Farmaceutici S.p.A.